Novoprotein Scientific Inc. (SHA:688137)

China · Delayed Price · Currency is CNY

40.03

+1.03 (2.64%)

Jul 14, 2026, 4:00 PM EDT

2.12% (1Y)

Market Cap	2.79B +8.7%
Revenue (ttm)	150.24M +11.4%
Net Income	-76.58M
EPS	-1.09
Shares Out	69.65M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,384,070
Open	38.99
Previous Close	39.00
Day's Range	37.55 - 40.18
52-Week Range	33.30 - 54.56
Beta	1.42
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Novoprotein Scientific

Novoprotein Scientific Inc. researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania. It offers cytokines, target proteins, mRNA vaccine and drug enzymes, recombinant antibodies, enzymes and reagents, biosimilar reference antibodies, gene and cell therapy, molecular research and diagnosis, and virus-related products, including antigens, antibodies and test kits. The company also provides protein expression and puri... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2009

Employees 636

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688137

Full Company Profile

Financial Performance

In 2025, Novoprotein Scientific's revenue was 146.44 million, an increase of 14.80% compared to the previous year's 127.56 million. Losses were -77.78 million, 42.9% more than in 2024.

Financial Statements